Lamond David
Insider CIK 1770790 · LHDX Director · CRTX Director · AMTI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 2,700 | — | $0 | 2,700 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-21 | 29,423 | — | $0 | 29,423 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 27,000 | — | $0 | 27,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-08 | 47,587 | — | $0 | 47,587 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 27,000 | — | $0 | 27,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-14 | 2023-12-14 | 22,627 | $1.04 | $23.5K | 2,347,545 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-13 | 2023-12-14 | 22,627 | $1.00 | $22.6K | 2,324,918 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-12 | 2023-12-14 | 22,327 | $1.02 | $22.8K | 2,302,291 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-12 | 2023-12-14 | 300 | $1.00 | $300 | 2,279,964 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-07 | 2023-12-07 | 19,123 | $1.01 | $19.3K | 2,279,664 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-06 | 2023-12-07 | 19,123 | $1.02 | $19.5K | 2,260,541 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-05 | 2023-12-07 | 19,123 | $1.01 | $19.3K | 2,241,418 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-12-01 | 2023-12-01 | 14,378 | $0.94 | $13.5K | 2,222,295 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-11-30 | 2023-12-01 | 14,378 | $0.90 | $12.9K | 2,207,917 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-11-29 | 2023-12-01 | 14,378 | $0.98 | $14.1K | 2,193,539 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-31 | 2023-08-31 | 41,026 | $1.32 | $54.2K | 2,179,161 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-30 | 2023-08-31 | 41,026 | $1.31 | $53.7K | 2,138,135 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-17 | 2023-08-17 | 24,766 | $1.29 | $31.9K | 2,097,109 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-16 | 2023-08-17 | 117,348 | $1.29 | $151.4K | 2,072,343 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-15 | 2023-08-17 | 107,886 | $1.32 | $142.4K | 1,954,995 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-26 | 27,000 | — | $0 | 27,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 27,000 | — | $0 | 27,000 | SEC↗ |
| LHDX Lucira Health, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 59,459 | — | $0 | 59,459 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award deriv | 2022-05-24 | 2022-05-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMTI Applied Molecular Transpor | P Buy | 2022-05-23 | 2022-05-23 | 33,500 | $3.26 | $109.2K | 1,077,519 | SEC↗ |
| AMTI Applied Molecular Transpor | P Buy | 2022-05-20 | 2022-05-23 | 33,000 | $3.08 | $101.6K | 1,044,019 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-05-19 | 2022-05-23 | 200,002 | — | $0 | 1,734,722 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 11,029 | — | $0 | 11,029 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award deriv | 2021-05-18 | 2021-05-20 | 15,175 | — | $0 | 15,175 | SEC↗ |
| AMTI Applied Molecular Transpor | P Buy | 2021-04-06 | 2021-04-07 | 25,000 | $42.00 | $1.05M | 1,011,019 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2021-03-24 | 2021-03-24 | 50,000 | $33.77 | $1.69M | 1,847,109 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2021-03-04 | 2021-03-05 | 4,100 | $36.86 | $151.1K | 1,797,109 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2021-03-04 | 2021-03-05 | 16,621 | $34.28 | $569.8K | 1,763,730 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2021-03-04 | 2021-03-05 | 13,310 | $35.00 | $465.9K | 1,777,040 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2021-03-04 | 2021-03-05 | 15,969 | $36.34 | $580.3K | 1,793,009 | SEC↗ |
| CRTX Cortexyme, Inc. | G Gift | 2021-03-04 | 2021-03-23 | 1,534,720 | — | $0 | 1,534,720 | SEC↗ |
| LHDX Lucira Health, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 53,629 | — | $0 | 0 | SEC↗ |
| LHDX Lucira Health, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 92,756 | — | $0 | 0 | SEC↗ |
| LHDX Lucira Health, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 53,629 | — | $0 | 53,629 | SEC↗ |
| LHDX Lucira Health, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 92,756 | — | $0 | 146,385 | SEC↗ |
| AMTI Applied Molecular Transpor | C Conversion deriv | 2020-06-09 | 2020-06-11 | 1 | — | $0 | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | C Conversion deriv | 2020-06-09 | 2020-06-11 | 1 | — | $0 | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | C Conversion deriv | 2020-06-09 | 2020-06-11 | 1 | — | $0 | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award | 2020-06-09 | 2020-06-11 | 71,430 | $14.00 | $1.00M | 986,019 | SEC↗ |
| AMTI Applied Molecular Transpor | C Conversion | 2020-06-09 | 2020-06-11 | 914,589 | — | $0 | 914,589 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-06-08 | 2020-06-09 | 11,029 | — | $0 | 11,029 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 10,642 | $43.32 | $461.0K | 1,722,235 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 24,874 | $43.88 | $1.09M | 1,747,109 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 13,609 | $42.13 | $573.3K | 1,711,593 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-19 | 2020-05-19 | 400 | $54.09 | $21.6K | 1,659,184 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-19 | 2020-05-19 | 5,906 | $55.42 | $327.3K | 1,665,090 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-19 | 2020-05-19 | 32,894 | $56.42 | $1.86M | 1,697,984 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 1,600 | $48.96 | $78.3K | 1,657,184 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 1,000 | $50.71 | $50.7K | 1,658,184 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 500 | $52.20 | $26.1K | 1,658,684 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 100 | $53.10 | $5.3K | 1,658,784 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 985 | $48.37 | $47.6K | 1,655,584 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2020-05-15 | 2020-05-19 | 1,263 | $46.30 | $58.5K | 1,654,599 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2020-02-10 | 2020-02-10 | 30,000 | $50.00 | $1.50M | 1,653,336 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 301,829 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 699,280 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 924,056 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 301,829 | — | $0 | 301,829 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 1,623,336 | — | $0 | 1,623,336 | SEC↗ |